08 August 2017
Visiongain’s new report the Healthcare Packaging Market Report 2017-2027: Forecasts by End-Use (Pharmaceuticals (OTC & Prescription (Rx)) & Medical Devices), By Material (Rigid Plastic, Flexible Plastic, Glass, Paper, Metal, Other), By Type (Plastic Bottles, Blister Packs, Caps & Closures, Pouches, Prefilled Syringes & Inhalers, Trays, Parenteral Vials & Ampoules, Other) Plus Analysis of Leading Companies indicates that the global healthcare packaging market will see $114.4 Bn in spending in 2017.
The lead analyst of the report said “Internationally, local packaging regulations and pharmaceutical companies’ packaging preferences are some of the drivers which will accelerate the growth of the healthcare packaging sector. Plastic packaging is gaining preference in the market and it will continue to grow due to the increasing trend to use prefillable syringes (PFS) in Europe, America and China. North American regulation has increased the consumption of Blister packaging and pharmaceutics companies have increased their production in this material, which is highly recognised for its benefits of making it easier for patients to follow their prescriptions, longevity, ease and speed of use, being childproof, and it is easy to customize.
However, China still presents opportunities for companies that can develop glass packaging using neutral borosilicate components. Despite the fact that plastic has been gaining place in the packaging pharmaceutical sector, glass packaging is still ahead for its recognized advantages such as: FDA approval, health and safety reasons, recyclability, odourless, hermetic seal, prolonged shelf life, leaching tendency, and its chemically inert, pure and transparent features. Glass is also recognised for its cost–effectiveness because pharmaceutical companies can increase sales due to being able to pack more medicines in glass containers. Additionally, the solid growth of ampoules consumption guarantees the long term use of glass packaging in the pharmaceutical industry.”
The 322-page report contains 289 tables, charts and graphs that add visual analysis in order to explain developing trends within the healthcare packaging market. Visiongain provides forecasts for the period 2017-2027 for the two leading healthcare packaging end-uses, namely pharmaceuticals, and medical devices. The report also includes segment forecasts for different materials rigid plastic, flexible plastic, glass, paper, metal, and others. The report further segments by type including plastic bottles, blister packs, caps & closures, pouches, prefilled syringes & inhalers, trays, parenteral vials & ampoules and other.
The comprehensive report offers market forecasts and analysis for several leading national markets and the rest of the world market. In addition, the report contains a dedicated leading companies’ chapter covering companies leading the field in healthcare packaging including Amcor, Ardagh Group, Becton, Dickinson & Co. (BD), Bemis Company, Inc., Gerresheimer, Mondi Ltd., Owens-Illinois, Inc. Sealed Air Corporation and SCHOTT.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 207 336 6100
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business conferences, newsletters, management reports and e-zines focusing on the automotive, chemical, cyber, defence, energy, pharmaceutical, materials and telecoms sectors.
Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Luxury packaging is an important specialised market in enormous packaging industry globally. Though it plays small part in the global packaging industry, the environmental impacts of it is on the heavier side.
22 May 2020
Global next-generation products in the tobacco market was valued at US$19.9 billion in 2019 and is anticipated to grow at a CAGR of 12.2% from 2020-2030 to reach at market value of US$48.6 billion by 2030. The market is anticipated to grow at a CAGR of 11.4% in the first half of the forecast period while the second half of the forecast period is anticipated to grow at CAGR of 12.9%.
07 May 2020
The global clinical research industry is in a transition phase as major giants are turning to emerging economies across the Asia Pacific to conduct clinical research which is projected to offer lucrative revenue generation avenues for the Clinical Trial Packaging & labelling competitors.
24 March 2020
Increasing awareness among manufacturers to tackle counterfeit products especially in developing countries is anticipated to boost the growth of active, smart and intelligent packaging at a significant rate during the forecast period.